Lab-on-chip reagent blister development kits available for diagnostics

J-Pac Medical, is offering development kits to allow customers to test the use of frangible and burst seal blisters with their microfluidic formats

Technology advancements in microfluidics are driving continued growth of point-of-care in-vitro diagnostics by enabling lab-on-chip test formats.

J-Pac Medical said its reagent blisters offer a solution for dispensing reagents on these test formats by allowing a unit of measure to be precisely delivered to a target well or reaction zone.

This delivery method reduces test complexity by storing and enabling the controlled release of testing reagents, eliminating the need for complex fluid handling, according to J-Pac Medical.

The company’s burst and frangible seal blisters deliver reagents on common lab-on-chip formats.

Burst blisters are typically used in applications where the test equipment pierces and evacuates the fluid and come in a dome format.

Frangible seal blister technology is used to deliver controlled release of reagents using J-Pac's differential seal technology.

Jeff Barrett, president and CEO, J-Pac Medical, said: "Frangible and burst seals offer a convenient way to bring new or improved diagnostic products to market quickly and affordably.

"We want to help our customers find the best blister for their microfluidic diagnostic platforms and are pleased to offer test kits that will help them explore the options that J-Pac can provide so they can make a more informed decision."